The University of Southampton
University of Southampton Institutional Repository

Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial

Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial

Background: In the UK, during the study period (April to July, 2021), all contacts of people with COVID-19 were required to self-isolate for 10 days, which had adverse impacts on individuals and society. Avoiding the need to self-isolate for those who remain uninfected would be beneficial. We investigated whether daily use of lateral flow devices (LFDs) to test for SARS-CoV-2, with removal of self-isolation for 24 h if negative, could be a safe alternative to self-isolation as a means to minimise onward transmission of the virus. Methods: We conducted a randomised, controlled, non-inferiority trial in adult contacts identified by COVID-19 contact tracing in England. Consenting participants were randomly assigned to self-isolation (single PCR test, 10-day isolation) or daily contact testing (DCT; seven LFD tests, two PCR tests, no isolation if negative on LFD); participants from a single household were assigned to the same group. Participants were prospectively followed up, with the effect of each intervention on onward transmission established from routinely collected NHS Test and Trace contact tracing data for participants who tested PCR-positive for SARS-CoV-2 during the study period and tertiary cases arising from their contacts (ie, secondary contacts). The primary outcome of the study was the attack rate, the percentage of secondary contacts (close contacts of SARS-CoV-2-positive study participants) who became COVID-19 cases (tertiary cases) in each group. Attack rates were derived from Bernoulli regression models using Huber-White (robust) sandwich estimator clustered standard errors. Attack rates were adjusted for household exposure, vaccination status, and ability to work from home. The non-inferiority margin was 1·9%. The primary analysis was a modified intention-to-treat analysis excluding those who actively withdrew from the study as data from these participants were no longer held. This study is registered with the Research Registry (number 6809). Data collection is complete; analysis is ongoing. Findings: Between April 29 and July 28, 2021, 54 923 eligible individuals were enrolled in the study, with final group allocations (following withdrawals) of 26 123 (52·6%) participants in the DCT group and 23 500 (47·4%) in the self-isolation group. Overall, 4694 participants tested positive for SARS-CoV-2 by PCR (secondary cases), 2364 (10·1%) in the self-isolation group and 2330 (8·9%) in the DCT group. Adjusted attack rates (among secondary contacts) were 7·5% in the self-isolation group and 6·3% in the DCT group (difference of –1·2% [95% CI –2·3 to –0·2]; significantly lower than the non-inferiority margin of 1·9%). Interpretation: DCT with 24 h exemption from self-isolation for essential activities appears to be non-inferior to self-isolation. This study, which provided evidence for the UK Government's daily lateral flow testing policy for vaccinated contacts of COVID-19 cases, indicated that daily testing with LFDs could allow individuals to reduce the risk of onward transmission while minimising the adverse effects of self-isolation. Although contacts in England are no longer required to isolate, the findings will be relevant for future policy decisions around COVID-19 or other communicable infections. Funding: UK Government Department of Health and Social Care.

Contacts, Covid-19, DCT, Lateral Flow Testing, SARS-CoV-2, Testing
2213-2600
1074-1085
Love, Nicola
f3f4f2aa-af53-4062-91e0-21b798a72f3e
Ready, Derren
bc11ef15-b8f9-4372-9750-fd9c55981796
Turner, Charlie
2d50607d-3fdf-4859-8c63-592c51d02395
Verlander, Neville
0e2b5dfc-a536-4698-a282-e072227ff86b
French, Clare
629c6728-19a8-421c-9356-ebd6cd588d50
Martin, Alex
e137f6f2-bc93-4939-b56c-9ff52b8d9fd9
Sorensen, Tina
d46f3e7d-4cde-4a14-8176-4709919579e6
Metelmann, Soeren
fdc53ff2-77bb-423b-9237-402ca24702fa
Denford, Sarah
8970b5a7-8cad-4356-ad0e-88297b67db37
Rubin, James
a1b1aed4-81d0-4a77-9731-988d6e242344
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Amlot, Richard
d93f5263-ea24-4b12-b505-f51694220b8e
Hopkins, Susan
8d271e32-f2bd-4ade-ba99-5b98ef0a007c
Oliver, Isabel
1598f598-b35d-42a4-9695-9b57c5ab15e9
Love, Nicola
f3f4f2aa-af53-4062-91e0-21b798a72f3e
Ready, Derren
bc11ef15-b8f9-4372-9750-fd9c55981796
Turner, Charlie
2d50607d-3fdf-4859-8c63-592c51d02395
Verlander, Neville
0e2b5dfc-a536-4698-a282-e072227ff86b
French, Clare
629c6728-19a8-421c-9356-ebd6cd588d50
Martin, Alex
e137f6f2-bc93-4939-b56c-9ff52b8d9fd9
Sorensen, Tina
d46f3e7d-4cde-4a14-8176-4709919579e6
Metelmann, Soeren
fdc53ff2-77bb-423b-9237-402ca24702fa
Denford, Sarah
8970b5a7-8cad-4356-ad0e-88297b67db37
Rubin, James
a1b1aed4-81d0-4a77-9731-988d6e242344
Yardley, Lucy
64be42c4-511d-484d-abaa-f8813452a22e
Amlot, Richard
d93f5263-ea24-4b12-b505-f51694220b8e
Hopkins, Susan
8d271e32-f2bd-4ade-ba99-5b98ef0a007c
Oliver, Isabel
1598f598-b35d-42a4-9695-9b57c5ab15e9

Love, Nicola, Ready, Derren, Turner, Charlie, Verlander, Neville, French, Clare, Martin, Alex, Sorensen, Tina, Metelmann, Soeren, Denford, Sarah, Rubin, James, Yardley, Lucy, Amlot, Richard, Hopkins, Susan and Oliver, Isabel (2022) Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial. The Lancet Respiratory Medicine, 10 (11), 1074-1085. (doi:10.1016/S2213-2600(22)00267-3).

Record type: Article

Abstract

Background: In the UK, during the study period (April to July, 2021), all contacts of people with COVID-19 were required to self-isolate for 10 days, which had adverse impacts on individuals and society. Avoiding the need to self-isolate for those who remain uninfected would be beneficial. We investigated whether daily use of lateral flow devices (LFDs) to test for SARS-CoV-2, with removal of self-isolation for 24 h if negative, could be a safe alternative to self-isolation as a means to minimise onward transmission of the virus. Methods: We conducted a randomised, controlled, non-inferiority trial in adult contacts identified by COVID-19 contact tracing in England. Consenting participants were randomly assigned to self-isolation (single PCR test, 10-day isolation) or daily contact testing (DCT; seven LFD tests, two PCR tests, no isolation if negative on LFD); participants from a single household were assigned to the same group. Participants were prospectively followed up, with the effect of each intervention on onward transmission established from routinely collected NHS Test and Trace contact tracing data for participants who tested PCR-positive for SARS-CoV-2 during the study period and tertiary cases arising from their contacts (ie, secondary contacts). The primary outcome of the study was the attack rate, the percentage of secondary contacts (close contacts of SARS-CoV-2-positive study participants) who became COVID-19 cases (tertiary cases) in each group. Attack rates were derived from Bernoulli regression models using Huber-White (robust) sandwich estimator clustered standard errors. Attack rates were adjusted for household exposure, vaccination status, and ability to work from home. The non-inferiority margin was 1·9%. The primary analysis was a modified intention-to-treat analysis excluding those who actively withdrew from the study as data from these participants were no longer held. This study is registered with the Research Registry (number 6809). Data collection is complete; analysis is ongoing. Findings: Between April 29 and July 28, 2021, 54 923 eligible individuals were enrolled in the study, with final group allocations (following withdrawals) of 26 123 (52·6%) participants in the DCT group and 23 500 (47·4%) in the self-isolation group. Overall, 4694 participants tested positive for SARS-CoV-2 by PCR (secondary cases), 2364 (10·1%) in the self-isolation group and 2330 (8·9%) in the DCT group. Adjusted attack rates (among secondary contacts) were 7·5% in the self-isolation group and 6·3% in the DCT group (difference of –1·2% [95% CI –2·3 to –0·2]; significantly lower than the non-inferiority margin of 1·9%). Interpretation: DCT with 24 h exemption from self-isolation for essential activities appears to be non-inferior to self-isolation. This study, which provided evidence for the UK Government's daily lateral flow testing policy for vaccinated contacts of COVID-19 cases, indicated that daily testing with LFDs could allow individuals to reduce the risk of onward transmission while minimising the adverse effects of self-isolation. Although contacts in England are no longer required to isolate, the findings will be relevant for future policy decisions around COVID-19 or other communicable infections. Funding: UK Government Department of Health and Social Care.

Text
LOVE - Lancet Res Med - Non-inferiority RCT onward infection transmission COVID - Accepted Manuscript
Download (67kB)

More information

Accepted/In Press date: 12 July 2022
e-pub ahead of print date: 10 October 2022
Published date: November 2022
Additional Information: Funding was provided by the UK Government Department of Health and Social Care. AFM is supported by the Economic and Social Research Council (grant number ES/J500057/1). We would like to thank the following teams for supporting the delivery of the trial: logistical and operational support from the NHS Test & Trace daily contact testing and home delivery teams (UKHSA and Department of Health and Social Care); recruitment support from the Agile Lighthouse team (UKHSA), NHSTT call handlers, and NHS 119 call handlers; administrative and mailbox support from the contact tracing administration team (UKHSA); data linkage by the Second Generation Surveillance System team and Field Service South West (UKHSA); and data support and advice from EpiCell and Contact tracing teams (UKHSA).
Keywords: Contacts, Covid-19, DCT, Lateral Flow Testing, SARS-CoV-2, Testing

Identifiers

Local EPrints ID: 468878
URI: http://eprints.soton.ac.uk/id/eprint/468878
ISSN: 2213-2600
PURE UUID: 39342f17-a623-44ba-98d6-4373a367a646
ORCID for Lucy Yardley: ORCID iD orcid.org/0000-0002-3853-883X

Catalogue record

Date deposited: 31 Aug 2022 16:43
Last modified: 17 Mar 2024 07:26

Export record

Altmetrics

Contributors

Author: Nicola Love
Author: Derren Ready
Author: Charlie Turner
Author: Neville Verlander
Author: Clare French
Author: Alex Martin
Author: Tina Sorensen
Author: Soeren Metelmann
Author: Sarah Denford
Author: James Rubin
Author: Lucy Yardley ORCID iD
Author: Richard Amlot
Author: Susan Hopkins
Author: Isabel Oliver

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×